EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dysregulated myeloid differentiation in colitis is induced by inflammatory osteoclasts in a TNFα-dependent manner

Maria-Bernadette Madel, Lidia Ibáñez, Thomas Ciucci, Julia Halper, Antoine Boutin, Ghada Beldi, Alice C Lavanant, Henri-Jean Garchon, Matthieu Rouleau, Christopher G Mueller, Laurent Peyrin-Biroulet, David Moulin und 2 weitere

Mucosal Immunology · 2025-02 · 18 (1) · 90-104

DOI: 10.1016/j.mucimm.2024.09.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mucosal Immunology, 2025-02. Verfasst von Maria-Bernadette Madel und 13 weiteren Autor:innen. Beteiligte Einrichtung: Université Côte d'Azur, CNRS, LP2M, Nice, France. Hauptthemen laut MEDLINE: Osteoclasts, Colitis, Tumor Necrosis Factor-alpha, Myeloid Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French National Research Agency, François Aupetit Association, Region Grand Est.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is characterized by very severe intestinal inflammation associated with extra-intestinal manifestations. One of the most critical ones is bone destruction, which remains a major cause of morbidity and a risk factor for osteopenia and osteoporosis in IBD patients. In various mouse models of IBD, we and other have demonstrated concomitant bone loss due to a significant increase in osteoclast activity. Besides bone resorption, osteoclasts are known to control hematopoietic niches in vivo and modulate inflammatory responses in vitro, suggesting they may participate in chronic inflammation in vivo. Here, using different models of colitis, we showed that osteoclast inhibition significantly reduced disease severity and that induction of osteoclast differentiation by RANKL contributed to disease worsening. Our results demonstrate a direct link between osteoclast activity and myeloid cell accumulation in the intestine during colitis. RNAseq analysis of osteoclasts from colitic mice revealed overexpression of genes involved in the remodeling of hematopoietic stem cell niches. We also demonstrated that osteoclasts induced hematopoietic progenitor proliferation accompanied by a myeloid skewing in the early phases of colitis, which was confirmed in a model of RANKL-induced osteoclastogenesis. Mechanistically, inhibition of TNF-α reduced the induction of myeloid skewing by OCL both in vitro and in vivo. Lastly, we observed that osteoclastic activity and the proportion of myeloid cells in the blood are positively correlated in patients with Crohn's disease. Collectively, our results shed light on a new role of osteoclasts in colitis in vivo, demonstrating they exert their colitogenic activity through an early action on hematopoiesis, leading to an increase in myelopoiesis sustaining gut inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoclastsColitisTumor Necrosis Factor-alphaMyeloid CellsAnimalsMiceCell DifferentiationDisease Models, AnimalHumansRANK LigandMice, Inbred C57BLInflammation

Stichwörter der Autor:innen

Inflammatory bowel diseaseMyeloid progenitor cellsOsteoclastOsteoporosisTNF-a

Substanzen

Tumor Necrosis Factor-alphaRANK Ligand

Autor:innen und Institutionen

  • Université Côte d'Azur, CNRS, LP2M, Nice, France.
  • David H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
  • CNRS UPR 3572, IBMC, University of Strasbourg, 67000 Strasbourg, France.
  • Université Paris-Saclay, UVSQ, INSERM, Infection et inflammation, 78180 Montigny-Le-Bretonneux, France.
  • Department of Gastroenterology, IHU INFINY, CHRU Nancy, F-54500 Vandœuvre-lès-Nancy, France; Université de Lorraine, INSERM, NGERE, F-54500 Vandoeuvre les Nancy, France.
  • Université de Lorraine, CNRS, IMoPA, F-54500 Vandœuvre Les Nancy, France; IHU INFINY, Contrat d'interface, CHRU Nancy, France.

Förderung

  • French National Research Agency
  • François Aupetit Association
  • Region Grand Est
  • European Regional Development Fund
  • Fondation pour la Recherche Médicale
  • Société Française de Rhumatologie
  • Université Côte d’Azur

Zitieren

APA

Madel, M. B., Ibáñez, L., Ciucci, T., Halper, J., Boutin, A., Beldi, G., Lavanant, A. C., Garchon, H. J., Rouleau, M., Mueller, C. G., Peyrin-Biroulet, L., Moulin, D., Blin-Wakkach, C., & Wakkach, A. (2025). Dysregulated myeloid differentiation in colitis is induced by inflammatory osteoclasts in a TNFα-dependent manner. Mucosal Immunology, 18(1), 90-104. https://doi.org/10.1016/j.mucimm.2024.09.005

Vancouver

Madel MB, Ibáñez L, Ciucci T, Halper J, Boutin A, Beldi G, et al. Dysregulated myeloid differentiation in colitis is induced by inflammatory osteoclasts in a TNFα-dependent manner. Mucosal Immunology. 2025;18(1):90-104. doi:10.1016/j.mucimm.2024.09.005

BibTeX
@article{Madel2025,
  author = {Madel, Maria-Bernadette and Ibáñez, Lidia and Ciucci, Thomas and Halper, Julia and Boutin, Antoine and Beldi, Ghada and Lavanant, Alice C and Garchon, Henri-Jean and Rouleau, Matthieu and Mueller, Christopher G and Peyrin-Biroulet, Laurent and Moulin, David and Blin-Wakkach, Claudine and Wakkach, Abdelilah},
  title = {Dysregulated myeloid differentiation in colitis is induced by inflammatory osteoclasts in a TNFα-dependent manner},
  journal = {Mucosal Immunology},
  year = {2025},
  volume = {18},
  number = {1},
  pages = {90--104},
  doi = {10.1016/j.mucimm.2024.09.005}
}
Kostenlos starten →